SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-401116
Filing Date
2014-11-06
Accepted
2014-11-06 16:33:36
Documents
12
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d788870d10q.htm 10-Q 636410
2 EX-10.1 d788870dex101.htm EX-10.1 65358
3 EX-31.1 d788870dex311.htm EX-31.1 6071
4 EX-31.2 d788870dex312.htm EX-31.2 6318
5 EX-32.1 d788870dex321.htm EX-32.1 2894
6 EX-32.2 d788870dex322.htm EX-32.2 3187
  Complete submission text file 0001193125-14-401116.txt   6599039

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT hptx-20140930.xml EX-101.INS 1066618
8 XBRL TAXONOMY EXTENSION SCHEMA hptx-20140930.xsd EX-101.SCH 50586
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hptx-20140930_cal.xml EX-101.CAL 84280
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hptx-20140930_def.xml EX-101.DEF 202421
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE hptx-20140930_lab.xml EX-101.LAB 469135
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hptx-20140930_pre.xml EX-101.PRE 337326
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 650-745-7802
HYPERION THERAPEUTICS INC (Filer) CIK: 0001386858 (see all company filings)

IRS No.: 611512713 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35614 | Film No.: 141201177
SIC: 2834 Pharmaceutical Preparations